middle.news
OncoSil Raises $8.7m to Accelerate Pancreatic Cancer Device Rollout
1:41am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
OncoSil Raises $8.7m to Accelerate Pancreatic Cancer Device Rollout
1:41am on Monday 2nd of June, 2025 AEST
Key Points
Firm commitments for $8.7m capital raise including $6.7m placement and $2m SPP
Cornerstone investor Pengana increases stake
Pro-forma cash balance of $14.1m to fund operations through H2 2026
Pivotal PANCOSIL and TRIPP-FFX trials nearing completion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Oncosil Medical (ASX:OSL)
OPEN ARTICLE